These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37022340)

  • 21. Pathomechanisms in the neuronal ceroid lipofuscinoses.
    Nelvagal HR; Lange J; Takahashi K; Tarczyluk-Wells MA; Cooper JD
    Biochim Biophys Acta Mol Basis Dis; 2020 Sep; 1866(9):165570. PubMed ID: 31678162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The neuronal ceroid lipofuscinoses: mutations in different proteins result in similar disease.
    Weimer JM; Kriscenski-Perry E; Elshatory Y; Pearce DA
    Neuromolecular Med; 2002; 1(2):111-24. PubMed ID: 12025857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cln3-mutations underlying juvenile neuronal ceroid lipofuscinosis cause significantly reduced levels of Palmitoyl-protein thioesterases-1 (Ppt1)-protein and Ppt1-enzyme activity in the lysosome.
    Appu AP; Bagh MB; Sadhukhan T; Mondal A; Casey S; Mukherjee AB
    J Inherit Metab Dis; 2019 Sep; 42(5):944-954. PubMed ID: 31025705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent Insight into the Genetic Basis, Clinical Features, and Diagnostic Methods for Neuronal Ceroid Lipofuscinosis.
    Kaminiów K; Kozak S; Paprocka J
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current Insights in Elucidation of Possible Molecular Mechanisms of the Juvenile Form of Batten Disease.
    Shematorova EK; Shpakovski GV
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33137890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A first CLN6 variant case of late infantile neuronal ceroid lipofuscinosis caused by a homozygous mutation in a boy from China: a case report.
    Sun G; Yao F; Tian Z; Ma T; Yang Z
    BMC Med Genet; 2018 Oct; 19(1):177. PubMed ID: 30285654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuronal Ceroid Lipofuscinosis Type 6 (CLN6) clinical findings and molecular diagnosis: Costa Rica's experience.
    Badilla-Porras R; Echeverri-McCandless A; Weimer JM; Ulate-Campos A; Soto-Rodríguez A; Gutiérrez-Mata A; Hernández-Con L; Bogantes-Ledezma S; Balmaceda-Meza A; Brudvig J; Sanabria-Castro A
    Orphanet J Rare Dis; 2022 Jan; 17(1):13. PubMed ID: 35012600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Using the social amoeba Dictyostelium to study the functions of proteins linked to neuronal ceroid lipofuscinosis.
    Huber RJ
    J Biomed Sci; 2016 Nov; 23(1):83. PubMed ID: 27881166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progress towards understanding the neurobiology of Batten disease or neuronal ceroid lipofuscinosis.
    Cooper JD
    Curr Opin Neurol; 2003 Apr; 16(2):121-8. PubMed ID: 12644737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioinformatic perspectives in the neuronal ceroid lipofuscinoses.
    Kmoch S; Stránecký V; Emes RD; Mitchison HM
    Biochim Biophys Acta; 2013 Nov; 1832(11):1831-41. PubMed ID: 23274885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A mixed breed dog with neuronal ceroid lipofuscinosis is homozygous for a CLN5 nonsense mutation previously identified in Border Collies and Australian Cattle Dogs.
    Villani NA; Bullock G; Michaels JR; Yamato O; O'Brien DP; Mhlanga-Mutangadura T; Johnson GS; Katz ML
    Mol Genet Metab; 2019 May; 127(1):107-115. PubMed ID: 31101435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outlook for future treatment.
    Zhong N; Wisniewski KE
    Adv Genet; 2001; 45():217-24. PubMed ID: 11332775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retention of lysosomal protein CLN5 in the endoplasmic reticulum causes neuronal ceroid lipofuscinosis in Asian sibship.
    Lebrun AH; Storch S; Rüschendorf F; Schmiedt ML; Kyttälä A; Mole SE; Kitzmüller C; Saar K; Mewasingh LD; Boda V; Kohlschütter A; Ullrich K; Braulke T; Schulz A
    Hum Mutat; 2009 May; 30(5):E651-61. PubMed ID: 19309691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of storage pathology in prenatal CLN5-deficient sheep neural cultures by lentiviral gene therapy.
    Hughes SM; Hope KM; Xu JB; Mitchell NL; Palmer DN
    Neurobiol Dis; 2014 Feb; 62():543-50. PubMed ID: 24269732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuronal ceroid lipofuscinoses.
    Jalanko A; Braulke T
    Biochim Biophys Acta; 2009 Apr; 1793(4):697-709. PubMed ID: 19084560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experimental gene therapies for the NCLs.
    Liu W; Kleine-Holthaus SM; Herranz-Martin S; Aristorena M; Mole SE; Smith AJ; Ali RR; Rahim AA
    Biochim Biophys Acta Mol Basis Dis; 2020 Sep; 1866(9):165772. PubMed ID: 32220628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glial Dysfunction and Its Contribution to the Pathogenesis of the Neuronal Ceroid Lipofuscinoses.
    Takahashi K; Nelvagal HR; Lange J; Cooper JD
    Front Neurol; 2022; 13():886567. PubMed ID: 35444603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular pathology and pathogenic aspects of neuronal ceroid lipofuscinoses.
    Kida E; Golabek AA; Wisniewski KE
    Adv Genet; 2001; 45():35-68. PubMed ID: 11332776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Canine neuronal ceroid lipofuscinoses: Promising models for preclinical testing of therapeutic interventions.
    Katz ML; Rustad E; Robinson GO; Whiting REH; Student JT; Coates JR; Narfstrom K
    Neurobiol Dis; 2017 Dec; 108():277-287. PubMed ID: 28860089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Neuronal Ceroid Lipofuscinoses-Linked Loss of Function CLN5 and CLN8 Variants Disrupt Normal Lysosomal Function.
    Parvin S; Rezazadeh M; Hosseinzadeh H; Moradi M; Shiva S; Gharesouran J
    Neuromolecular Med; 2019 Jun; 21(2):160-169. PubMed ID: 30919163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.